Incidência de Klebsiella pneumoniae produtoras de beta-lactamases de espectro estendido em pacientes com infecção do trato urinário
Palavras-chave:
Klebsiella pneumoniae, Beta-lactamases, Infecções urinárias, Cefalosporinas, Irã (geográfico)Resumo
CONTEXTO E OBJETIVOS: As bactérias resistentes estão surgindo em todo o mundo como uma ameaça ao resultado favorável no tratamento de infecções comuns em ambientes comunitários e hospitalares. O presente estudo foi realizado com o objetivo de avaliar a incidência de Klebsiella pneumoniae produtoras de beta-lactamases de espectro estendido (BLEEs) em pacientes com infecção do trato urinário em diferentes estações do ano, para verificar a prevalência dos genes blaTEM, blaSHV e blaCTX-M responsáveis para a produção de BLEEs em K. pneumoniae productoras de BLEEs, em três cidades do Irã, e investigar o perfil de sensibilidade antimicrobiana de K. pneumoniae em diferentes estações. DESENHO E LOCAL: Estudo retrospectivo realizado em pacientes com infecções do trato urinário em cinco hospitais no Irã. MÉTODO: Duzentos e oitenta e oito isolados clínicos de K. penumoniae foram coletados entre março de 2007 e abril de 2008 em cinco hospitais de três cidades no Irã. BLEEs foram identificados por métodos fenotípicos e genotípicos. K. pneumoniae produtoras de BLEEs foram avaliadas contra antibióticos não beta-lactâmicos. Os genes codificadores de BLEEs (blaSHV, TEM e CTX-M) foram investigados. RESULTADOS: Entre os 288 isolados clínicos de K. pneumoniae, 37,7%, 46,7% e 15,6% eram provenientes dos hospitais em Ilam, Tehran e Tabriz, respectivamente, dos quais 39,4%, 50,7% e 45,8% eram K. pneumoniae produtoras de BLEEs nos hospitais em Ilam, Milad e Eman Reza, respectivamente. CONCLUSÃO: De acordo com os resultados deste estudo, a resistência às cefalosporinas de terceira geração é maior nos meses frios do que nos meses quentes.
Downloads
Referências
Chaudhary U, Aggarwal R. Extended spectrum -lactamases (ESBL) - an emerging threat to clinical therapeutics. Indian J Med Microbiol. 2004;22(2):75-80.
Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11(6):315-7.
Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933-51, table of contents.
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657-86.
Winokur PL, Brueggemann A, DeSalvo DL, et al. Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother. 2000;44(10):2777-83.
Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-
ceftazidime-hydrolyzing beta-lactamases in a single isolates. Antimicrob Agents Chemother. 1994;38(4):761-6.
Pangon B, Bizet C, Buré A, et al. In vivo selection of a cephamycin- resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J Infect Dis. 1989;159(5):1005-6.
Sirot D. Extended-spectrum plasmid-mediated beta-lactamases. J Antimicrob Chemother. 1995;36 Suppl A:19-34.
Villa L, Pezzella C, Tosini F, et al. Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended- spectrum beta-lactamase gene and a class 1 integron. Antimicrob Agents Chemother. 2000;44(10):2911-4.
Paterson DL, Ko WC, Von Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol. 2001;39(6):2206-12.
Irajian G, Moghadas AJ. Frequency of extended-spectrum beta lactamase positive and multidrug resistance pattern in Gram- negative urinary isolates, Semnan, Iran. Jundishapur Journal of Microbiology. 2010;3(3):107-13. Available from: http://jjm.ajums.ac.ir/_jjm/documents/Issue%208GI.pdf. Accessed in 2011 (Jun 15).
Mac Faddin JF. Biochemical tests for identification of medical bacteria. 3rd ed. Philadelphia: Lippincott Williams & Wilkinson; 1999.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement, M100-S20. Wayne: Clinical and Laboratory Standards Institute; 2010. Available from: http://www.clsi.org/source/orders/free/m100-s20.pdf. Accessed in 2011 (Jun 15).
Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30(3):473-8.
Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit. 2007;13(11):BR247-250.
Mansouri M, Ramazanzadeh R. Spread of extended-spectrum beta- lactamase producing Escherichia coli clinical isolates in Sanandaj Hospitals. Journal of Biological Sciences. 2009;9(4):362-66. Available from: http:// scialert.net/abstract/?doi=jbs.2009.362.366. Accessed in 2011 (Jun 15).
Bush K. The impact of beta-lactamases on the development of novel antimicrobial agents. Curr Opin Investig Drugs. 2002;3(9):1284-90.
Shannon K, Phillips I. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. J Antimicrob Chemother. 1986;18 Suppl E:15-22.
Yu Y, Zhou W, Chen Y, Ding Y, Ma Y. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province. Chin Med J (Engl). 2002;115(10):1479-82.
Alzahrani AJ, Akhtar N. Susceptibility patterns of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital. Pakistan Journal of Medical Research. 2005;44(2):64-7. Available from: http://www. pakmedinet.com/8334. Accessed in 2011 (Jun 15).
Podschun R, Ullmann C. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589-603.
Livermore DM. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995;8(4):557-84.
Arlet G, Philippon A. Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV, CARB) FEMS Microbiol Lett. 1991;66(1):19-25.
Elo J, Sarna S, Tallgren LG. Seasonal variations in the occurrence of urinary tract infections among children in an urban area in Finland. Ann Clin Res. 1979;11(3):101-6.
Stansfeld JM. Clinical observations relating to incidence and aetiology of urinary-tract infections in children. Be Med J. 1966;1(5488):631-5.
Behrooozi A, Rahbar M, Vand Yousefi J. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. African Journal of Microbiology Research. 2010;4(9):881-4. Available from: http://www.academicjournals.org/ajmr/PDF/Pdf2010/4May/Behrooozi%20et%20al.pdf. Accessed in 2011 (Jun 15).
Jain A, Mondal R. Prevalence & antimicrobial resistance pattern of extended spectrum beta-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia. Indian J Med Res. 2007;125(1):89-94.
Bameri Z, Chitsaz M, Owlia P. Detection of CTX-M - Lactamases in Isolated Klebsiella pneumoniae. Iranian Journal of Pathology. 2010;5(3):137-42. Available from: http://www.ijp.iranpath.org/IJPArticles/5_3/6.pdf. Accessed in 2011 (Jun 15).
Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med. 2009;29(4):253-7.
Tasli H, Bahar IH. Molecular characterization of TEM- and SHV- derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis. 2005;58(3):162-7.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
